First Interstate Bank’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,114
Closed -$16K 724
2017
Q1
$16K Hold
1,114
﹤0.01% 485
2016
Q4
$21K Hold
1,114
﹤0.01% 463
2016
Q3
$18K Hold
1,114
﹤0.01% 489
2016
Q2
$15K Hold
1,114
﹤0.01% 509
2016
Q1
$17K Hold
1,114
﹤0.01% 498
2015
Q4
$22K Buy
1,114
+144
+15% +$2.74K ﹤0.01% 465
2015
Q3
$17K Buy
+970
New +$19.8K ﹤0.01% 525

Other funds holding AMRI

First Interstate Bank's AMRI Position: Q2 2017 in Review

First Interstate Bank sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 1,114 shares — an estimated $16K sold.

First Interstate Bank first reported a position in AMRI in Q3 2015 and held it in 7 quarters. The position peaked at $22K in Q4 2015. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • First Interstate Bank reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • First Interstate Bank sold 1,114 Albany Molecular Research Inc shares in Q2 2017, an estimated $16K.
  • First Interstate Bank first reported a position in Albany Molecular Research Inc in Q3 2015 and held it in 7 quarters.
  • First Interstate Bank's Albany Molecular Research Inc position peaked at $22K in Q4 2015.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on First Interstate Bank's 13F filing for Q2 2017, filed 7 Aug 2017.